DOTA-CXCR4-L
DOTA-CXCR4-L is a CXCR4 targeting peptide. DOTA-CXCR4-L can be used in the study of cancers, including glioblastoma and triple-negative breast cancer. NODAGA-LM3 can be labeled with [68Ga]/[177Lu] for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).
For research use only. We do not sell to patients.
- Formula: C58H78N16O14
- Molecular Weight:1223.34
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All Radionuclide-Drug Conjugates (RDCs) Isoforms
More
Biological Activity
|
RDC Peptide |
Chemical Information
-
Molecular Weight 1223.34
-
Formula C58H78N16O14
-
Sequence
cyclo[{d-Tyr}-{d-(NMe)Orn}-(HYNIC-DOTA)-Arg-{Nal}-Gly)]
-
Sequence Shortening
cyclo[{d-Tyr}-{d-(NMe)Orn}-(HYNIC-DOTA)-R-{Nal}-G)]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
DOTA-CXCR4-L Related Classifications
HY-P5297 Related Classifications
Powered by Bioz